GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Marpai Inc (NAS:MRAI) » Definitions » Cash Conversion Cycle

Marpai (Marpai) Cash Conversion Cycle : -70.15 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Marpai Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Marpai's Days Sales Outstanding for the three months ended in Mar. 2024 was 9.21.
Marpai's Days Inventory for the three months ended in Mar. 2024 was 0.
Marpai's Days Payable for the three months ended in Mar. 2024 was 79.36.
Therefore, Marpai's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2024 was -70.15.


Marpai Cash Conversion Cycle Historical Data

The historical data trend for Marpai's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marpai Cash Conversion Cycle Chart

Marpai Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
- - -17.71 -15.17 -33.39

Marpai Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.08 -21.25 -31.69 -50.93 -70.15

Competitive Comparison of Marpai's Cash Conversion Cycle

For the Healthcare Plans subindustry, Marpai's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marpai's Cash Conversion Cycle Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Marpai's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Marpai's Cash Conversion Cycle falls into.



Marpai Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Marpai's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=12.59+0-45.98
=-33.39

Marpai's Cash Conversion Cycle for the quarter that ended in Mar. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=9.21+0-79.36
=-70.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marpai  (NAS:MRAI) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Marpai Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Marpai's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Marpai (Marpai) Business Description

Traded in Other Exchanges
N/A
Address
5701 East Hillsborough Avenue, Suite 1417, Tampa, FL, USA, 33610-5428
Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients' health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States.
Executives
Yaron Eitan director 65 CHALLENGER ROAD, RIDGEFIELD PARK NJ 07660
Damien Lamendola director, 10 percent owner 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Edmundo Gonzalez director, officer: CEO, Secretary and Director C/O SELWAY CAPITAL ACQUISITION CORP., 74 GRAND AVENUE, 2ND FLOOR, ENGLEWOOD NJ 07631
Sagiv Shiv director
Vincent Kane director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131
Ronnie Brown officer: Chief Operating Officer 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Mohsen Moazami director C/O ASTREA ACQUISITION CORP., 55 OCEAN LANE DRIVE, APT. 3021, KEY BISCAYNE FL 33149
Lutz Finger officer: See Remarks 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610
Yoram Bibring officer: Chief Financial Officer C/O SELWAY ACQUISITION CORPORATION, 66 FORD ROAD, SUITE 230, DENVILLE NJ 07834
Jane Cavalier director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Diclaudio Colleen director 456 SEATON STREET, LOS ANGELES CA 90013
Art Hoath officer: Chief Revenue Officer 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Gonen Antebi director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Eli David other: See footnote (1) 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131

Marpai (Marpai) Headlines

From GuruFocus

Marpai Hires Gonen Antebi as Chief Operating Officer

By Business Wire Business Wire 02-07-2023

Marpai Announces Virta as Diabetes Premium Health Partner

By PRNewswire PRNewswire 11-16-2022

Marpai, Inc. Announces Pricing of Public Offering

By Business Wire Business Wire 04-17-2023

Marpai Announces Reverse Stock Split

By PRNewswire 06-28-2023

Marpai To Acquire Maestro Health

By PRNewswire PRNewswire 08-04-2022